首頁 > 市場調查報告書 > 醫療設備

生技設備

晶片器官市場規模、佔有率和成長分析（按器官類型、模型類型、產品類型、用途、應用、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1904467

晶片器官市場規模、佔有率和成長分析（按器官類型、模型類型、產品類型、用途、應用、最終用戶和地區分類）－2026-2033年產業預測

Organ on Chip Market Size, Share, and Growth Analysis, By Organ Type (Liver, Kidney), By Model Type, By Product, By Purpose, By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，晶片器官市場規模將達到 897.4 億美元，到 2025 年將成長至 1,173.4 億美元，到 2033 年將成長至 10,291 億美元，在預測期（2026-2033 年）內複合年成長率為 30.76%。

受動物實驗替代方案的需求以及對藥物反應和毒性早期檢測的迫切需求驅動，器官晶片市場正經歷顯著成長。這些微流體裝置能夠模擬特定器官的功能，進而應用於疾病建模、藥物研發和毒性評估等領域。科技的快速進步以及製藥、生物技術和學術機構的日益普及，正進一步推動市場成長。此外，隨著相關人員探索傳統器官以外的新應用領域，並推動器官晶片技術在醫療保健領域的整合，預計該市場將蓬勃發展。尤其是在新冠疫情爆發後，研究能力的提升和對器官晶片技術日益成長的興趣，預示著該技術將擁有一個充滿活力的未來，並將不斷湧現創新成果以滿足研究界不斷變化的需求。

晶片器官市場促進因素

在全球範圍內，反對動物實驗的運動日益高漲，這對器官晶片市場產生了重大影響。消費者意識的不斷增強，推動了對器官晶片平台的需求成長，這些平台能夠促進藥物研發、毒性測試及其他相關應用。這些創新技術提供人道、合乎倫理且有效率的解決方案，符合那些呼籲終止動物實驗的人們的訴求。隨著人們對倫理測試方法的日益關注，器官晶片系統正成為重要的工具，有望改善研究成果，並徹底革新製藥和生物醫學產業的測試流程。

晶片器官市場的限制因素

由於涉及人體細胞、組織和器官研究的倫理問題，器官晶片市場面臨許多限制。知情同意、隱私以及生物材料倫理來源等方面的擔憂，使該行業格局變得複雜。必須認真考慮與這項技術相關的法律和社會影響，包括動物福利問題，並在市場中推廣負責任的創新和永續實踐。解決這些倫理困境對於建立公眾信任、確保器官晶片技術的發展符合社會價值和規範至關重要，最終影響其廣泛接受度和應用。

晶片器官市場趨勢

在製藥業成本不斷攀升和麵臨諸多挑戰的背景下，器官晶片市場正呈現出顯著的成長趨勢，即提高藥物安全性和有效性預測的準確性。隨著傳統方法的限制日益凸顯，各公司正加速採用器官晶片技術，以期為藥物測試提供更準確、更貼近人體實際的數據。這種創新方法使研究人員能夠模擬人體器官對治療藥物的反應，從而提高預測準確性，並顯著減少對動物實驗的依賴。因此，對先進器官晶片模型的研發投入不斷增加，這些模型有望透過簡化研發流程和縮短新治療方法上市時間，徹底革新藥物發現過程。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2021-2023年營收年比比較

主要企業簡介

Emulate, Inc.
Mimetas BV
Tissuse GmbH
CN Bio Innovations Ltd.
InSphero
Alveolix AG
Fluigent

結論與建議

簡介目錄

Product Code: SQMIG35A2896

Organ on Chip Market size was valued at USD 89.74 Billion in 2024 and is poised to grow from USD 117.34 Billion in 2025 to USD 1002.91 Billion by 2033, growing at a CAGR of 30.76% during the forecast period (2026-2033).

The organ-on-chip market is experiencing significant growth, driven by the demand for alternatives to animal testing and the urgency for early detection of drug reactions and toxicity. These microfluidic devices replicate specific organ functions, enabling applications in disease modeling, drug development, and toxicity assessment. Rapid technological advancements and increasing adoption across pharmaceuticals, biotech, and academic institutions are further propelling market expansion. Furthermore, as stakeholders explore new applications beyond traditional organs and improve integration into healthcare sectors, the market is expected to flourish. Enhanced research capabilities and the growing interest in organ-on-chip technologies, especially following the Covid-19 pandemic, indicate a robust future, with ongoing innovations anticipated to meet the evolving needs of the research community.

Top-down and bottom-up approaches were used to estimate and validate the size of the Organ on Chip market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Organ on Chip Market Segments Analysis

Global Organ On Chip Market is segmented by organ type, model type, product, purpose, application, end user and region. Based on organ type, the market is segmented into liver, kidney, intestine, lung, heart and other organs. Based on model type, the market is segmented into organ-based models and disease-based models. Based on product, the market is segmented into services and products. Based on purpose, the market is segmented into therapeutics and research. Based on application, the market is segmented into toxicology research, drug discovery, physiological model development, tissue regeneration ®enerative medicineand stem cell research. Based on end user, the market is segmented into pharmaceutical and biotechnology companies, cosmetics industry, academic & research institutes and other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Organ on Chip Market

There is a growing global movement advocating for alternatives to animal testing, which significantly impacts the Organ on Chip market. This heightened awareness among consumers is driving an increased demand for organ-on-chip platforms that facilitate drug discovery, toxicity testing, and other related applications. These innovative technologies offer humane, ethical, and efficient solutions that align with the desires of those seeking to eliminate animal experimentation. As the focus on ethical testing methods escalates, organ-on-chip systems are emerging as crucial tools, providing the potential to enhance research outcomes and revolutionize how pharmaceutical and biomedical industries approach testing processes.

Restraints in the Organ on Chip Market

The Organ-on-Chip market faces notable restraints due to ethical considerations related to the utilization of human cells, tissues, and organs in research. Concerns surrounding informed consent, privacy, and the ethical sourcing of biological materials complicate the industry landscape. It is crucial to navigate the legal and societal implications associated with this technology, including matters of animal welfare, to promote responsible innovation and sustainable practices within the market. Addressing these ethical dilemmas is essential for fostering public trust and ensuring that the development of organ-on-chip technologies aligns with societal values and norms, ultimately influencing their widespread acceptance and application.

Market Trends of the Organ on Chip Market

The Organ-on-Chip market is witnessing a notable trend toward enhancing drug safety and effectiveness predictions amidst the escalating costs and challenges faced by the pharmaceutical industry. As traditional methods prove inadequate, companies are increasingly adopting organ-on-chip technologies to provide more accurate, human-relevant data for drug testing. This innovative approach enables researchers to simulate human organ responses to therapeutic compounds, significantly reducing reliance on animal testing and improving predictive capabilities. Consequently, there is a growing investment in the development of sophisticated organ-on-chip models, which are anticipated to revolutionize the drug discovery process by streamlining research and accelerating time-to-market for new therapies.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Patent Analysis
Case Study Analysis
Trade Analysis
Customer & Buying Criteria Analysis

Global Organ On Chip Market Size by Organ Type & CAGR (2026-2033)

Market Overview
Liver
Kidney
Intestine
Lung
Heart
Other Organs

Global Organ On Chip Market Size by Model Type & CAGR (2026-2033)

Market Overview
Organ-Based Models
Disease-Based Models

Global Organ On Chip Market Size by Product & Service & CAGR (2026-2033)

Market Overview
Services
- Custom Services
- Standard Services
Products
- Instruments
- Consumables & Accessories
- Software

Global Organ On Chip Market Size by Purpose & CAGR (2026-2033)

Market Overview
Therapeutics
Research

Global Organ On Chip Market Size by Application & CAGR (2026-2033)

Market Overview
Toxicology Research
Drug Discovery
Physiological Model Development
Tissue Regeneration & Regenerative Medicine
Stem Cell Research

Global Organ On Chip Market Size by End User & CAGR (2026-2033)

Market Overview
Pharmaceutical And Biotechnology Companies
Cosmetics Industry
Academic & Research Institutes
Other End Users

Global Organ On Chip Market Size & CAGR (2026-2033)

North America (Organ Type, Model Type, Product & Service, Purpose, Application, End User)
- US
- Canada
Europe (Organ Type, Model Type, Product & Service, Purpose, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Organ Type, Model Type, Product & Service, Purpose, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Organ Type, Model Type, Product & Service, Purpose, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Organ Type, Model Type, Product & Service, Purpose, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Emulate, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mimetas B.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tissuse GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CN Bio Innovations Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
InSphero
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alveolix AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluigent
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments